相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Gail J. Roboz et al.
BLOOD (2020)
Immunological role and underlying mechanisms of B7-H6 in tumorigenesis
Yuxuan Hu et al.
CLINICA CHIMICA ACTA (2020)
The integrated stress response promotes B7H6 expression
Akram Obiedat et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity
Ida Sofie Gronningsaeter et al.
CELLS (2020)
Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer
Xiuqin Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Anticancer mechanisms of metformin: A review of the current evidence
Bin Zhao et al.
LIFE SCIENCES (2020)
B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data
Siyuan Yang et al.
ONCOTARGETS AND THERAPY (2020)
Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets
Dan Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Emerging roles of and therapeutic strategies targeting BRD4 in cancer
Mary E. White et al.
CELLULAR IMMUNOLOGY (2019)
Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Role of Mitochondria in the Mechanism(s) of Action of Metformin
Guillaume Vial et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Phase 1 Dose Escalation and Expansion Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BET Inhibitor FT-1101 As a Single Agent in Patients with Relapsed or Refractory Hematologic Malignancies
Manish R. Patel et al.
BLOOD (2019)
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
Valentina Gambacorta et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3
Yi-Ming Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The prognostic value of B7-H6 in esophageal squamous cell carcinoma
Huan Zhou et al.
SCIENTIFIC REPORTS (2019)
Epigenetic effects of metformin: From molecular mechanisms to clinical implications
Stephanie Claire Bridgeman et al.
DIABETES OBESITY & METABOLISM (2018)
Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer
Sunmi Park et al.
ENDOCRINE-RELATED CANCER (2018)
B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas
Fengyuan Che et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
Yan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
Elisabet Cuyas et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1
Traci L. Marin et al.
SCIENCE SIGNALING (2017)
Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer
Jing Sun et al.
ONCOLOGY LETTERS (2017)
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien et al.
ONCOTARGET (2017)
AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1
Traci L. Marin et al.
SCIENCE SIGNALING (2017)
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Prajwal Boddu et al.
BLOOD ADVANCES (2017)
The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia
G. Giotopoulos et al.
ONCOGENE (2016)
Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
Feifei Wu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Mammalian Heat Shock Response and Mechanisms Underlying Its Genome-wide Transcriptional Regulation
Dig B. Mahat et al.
MOLECULAR CELL (2016)
BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements
Anand S. Bhagwat et al.
CELL REPORTS (2016)
Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer
Fade Gong et al.
PLOS GENETICS (2016)
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Celine Berthon et al.
LANCET HAEMATOLOGY (2016)
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Sonja Textor et al.
ONCOIMMUNOLOGY (2016)
Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6
Guoshuai Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity
Ming-Ru Wu et al.
JOURNAL OF IMMUNOLOGY (2015)
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
Silvia Pesce et al.
ONCOIMMUNOLOGY (2015)
RNA polymerase II pausing during development
Bjoern Gaertner et al.
DEVELOPMENT (2014)
Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
Friederike Itzen et al.
NUCLEIC ACIDS RESEARCH (2014)
Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
Jessica Matta et al.
BLOOD (2013)
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Nathalie Fiegler et al.
BLOOD (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release
Wen Liu et al.
CELL (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Transcriptional Pausing Controls a Rapid Antiviral Innate Immune Response in Drosophila
Jie Xu et al.
CELL HOST & MICROBE (2012)
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem-and progenitor cells in acute myeloid leukemia (AML)
Harald Herrmann et al.
ONCOTARGET (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
Tomonori Kaifu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
Yili Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies
AAN Giagounidis et al.
CLINICAL CANCER RESEARCH (2006)
Regulation of transcription by AMP-activated protein kinase - Phosphorylation of p300 blocks its interaction with nuclear receptors
WB Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
